{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T20:49:21Z","timestamp":1782852561271,"version":"3.54.5"},"reference-count":24,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Head and neck tumors are common in Slovakia. Although the number of tumors associated with smoking and alcohol is decreasing, the number of tumors associated with human papilloma-virus increases. Radiotherapy plays an important role in their treatment. The thyroid gland, due to its oneself location, is predisposed to the development of post-radiation dysfunction. Nowadays, there are methods able to reduce this risk and also available new options for treatment and dispensary care for these patients. The aim of this work is to analyze the incidence and pathophysiological mechanisms of post-radiation hypothyroidism in patients with head and neck tumors, to highlight the risk factors associated with radiotherapy and evaluation of prevention possibilities and treatments, and an overview of modern therapeutic approaches. Special attention is devoted to the importance of a multidisciplinary approach and the need for a long-term patient monitoring as well as the assessment of thyroid function as an integral part of a comprehensive oncological care.<\/jats:p>","DOI":"10.2478\/enr-2025-0029","type":"journal-article","created":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T06:01:43Z","timestamp":1765605703000},"page":"255-259","source":"Crossref","is-referenced-by-count":0,"title":["Post-radiation hypothyroidism in patients with head and neck tumors: An overview assessment"],"prefix":"10.2478","volume":"59","author":[{"given":"Elena","family":"Bukvayova","sequence":"first","affiliation":[{"name":"Clinic of Otorhinolaryngology and Head and Neck Surgery, Jessenius Faculty of Medicine Martin, Comenius University Bratislava , University Hospital Martin , Martin , Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Kafkova","sequence":"additional","affiliation":[{"name":"Clinic of Otorhinolaryngology and Head and Neck Surgery, Jessenius Faculty of Medicine Martin, Comenius University Bratislava , University Hospital Martin , Martin , Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"key":"2026063014591890158_j_enr-2025-0029_ref_001","doi-asserted-by":"crossref","unstructured":"Abalovich M, Amino N, Barbour LA, Cobin RH, De Groot LJ, Glinoer D, Mandel SJ, Stagnaro-Green A. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 92, S1\u201347, 2007.","DOI":"10.1210\/jc.2007-0141"},{"key":"2026063014591890158_j_enr-2025-0029_ref_002","unstructured":"Ballova V. Vylieceny pacient po onkologickej liecbe v ambulancii vseobecneho lekara. Via Practica 14, 121\u2013125, 2017."},{"key":"2026063014591890158_j_enr-2025-0029_ref_003","doi-asserted-by":"crossref","unstructured":"Bourhis J, Overgaard J, Audry H, Ang KK, Saunders M, Bernier J. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a metaanalysis. Lancet 368, 843\u2013854, 2006.","DOI":"10.1016\/S0140-6736(06)69121-6"},{"key":"2026063014591890158_j_enr-2025-0029_ref_004","doi-asserted-by":"crossref","unstructured":"Chaturvedi AK, Anderson WF, Lortet-Tieulent J, Curado MP, Ferlay J, Franceschi S. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol 31, 4550\u20134559, 2013.","DOI":"10.1200\/JCO.2013.50.3870"},{"key":"2026063014591890158_j_enr-2025-0029_ref_005","doi-asserted-by":"crossref","unstructured":"Chow JCH, Cheung KM, Cheung GTC, Tam AHP, Lui JCF, Lee FKH, Au KH, Ng WT, Lee AWM, Yiu HHY. Dose-volume predictors of post-radiation primary hypothyroidism in head and neck cancer: A systematic review. Clin Transl Radiat Oncol 33, 83\u201392, 2022.","DOI":"10.1016\/j.ctro.2022.01.001"},{"key":"2026063014591890158_j_enr-2025-0029_ref_006","doi-asserted-by":"crossref","unstructured":"Diana G, Corica C. Human Papilloma Virus vaccine and prevention of head and neck cancer, what is the current evidence? Oral Oncol 115, 105168, 2021.","DOI":"10.1016\/j.oraloncology.2020.105168"},{"key":"2026063014591890158_j_enr-2025-0029_ref_007","unstructured":"Diba CHS, Hlava P. Incidencia zhubn\u00fdch nadorov v Slovenskej republike v roku 2009. Bratislava: Vydavatelstvo NCZI, 2015."},{"key":"2026063014591890158_j_enr-2025-0029_ref_008","unstructured":"Dobrovic MS, Sicak MM. Neskora alebo nespravna diagnostika a liecba nadorov hlavy a krku \u2013 kazuistiky. Onkologia 12, 258\u2013261, 2017."},{"key":"2026063014591890158_j_enr-2025-0029_ref_009","unstructured":"Dorr RT, Holmes BC. Dosing considerations with amifostine: a review of the literature and clinical experience. Semin Oncol 26, 108\u2013119, 1999."},{"key":"2026063014591890158_j_enr-2025-0029_ref_010","doi-asserted-by":"crossref","unstructured":"Fu KK, Pajak TF, Trotti A, Jones CU, Spencer SA, Phillips TL, Garden AS, Ridge JA, Cooper JS, Ang KK. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 48, 7\u201316, 2000.","DOI":"10.1016\/S0360-3016(00)00663-5"},{"key":"2026063014591890158_j_enr-2025-0029_ref_011","unstructured":"Hynkova L, Dolezelova H. Nezadouci ucinky radioterapie a podpurna lecba u radioterapie nadoru hlavy a krku. Onkologie 2, 88\u201390, 2008."},{"key":"2026063014591890158_j_enr-2025-0029_ref_012","doi-asserted-by":"crossref","unstructured":"Jiskra J, Limanova Z, Vanickova Z, Kocna P. IgA and IgG antigliadin, IgA anti-tissue transglutaminase and antiendomysial antibodies in patients with autoimmune thyroid diseases and their relationship to thyroidal replacement therapy. Physiol Res 52, 79\u201388, 2003.","DOI":"10.33549\/physiolres.930339"},{"key":"2026063014591890158_j_enr-2025-0029_ref_013","unstructured":"Jiskra J. Racionalni diagnostika a lecba nemoci stitne zlazy. Med Pro Praxi 7, 167\u2013172, 2010."},{"key":"2026063014591890158_j_enr-2025-0029_ref_014","unstructured":"Kubes J, Cvek J. Konformni radioterapie v lecbe nadoru hlavy a krku. Onkologie 2, 79\u201381, 2008."},{"key":"2026063014591890158_j_enr-2025-0029_ref_015","doi-asserted-by":"crossref","unstructured":"Miller MC, Agrawal A. Hypothyroidism in postradiation head and neck cancer patients: incidence, complications, and management. Curr Opin Otolaryngol Head Neck Surg 17, 111\u2013115, 2009.","DOI":"10.1097\/MOO.0b013e328325a538"},{"key":"2026063014591890158_j_enr-2025-0029_ref_016","unstructured":"Osterreicher J, Vavrova J, Stulik J, et al. Molekularni a bunecne zmeny po expozici ionizujiciho zazeni. In: Kuna P, Navratil L, et al. Klinick\u00e1 radiobiologie, 1. vydani, Manus 34\u201345, 2005."},{"key":"2026063014591890158_j_enr-2025-0029_ref_017","unstructured":"Petera J, Odrazka K, Zouhar M. Principy radioterapie. Slampa P, Petera J, et al. Radiacni onkologie. 1st ed. Praha: Galen Karolinum, 11\u201365, 2007."},{"key":"2026063014591890158_j_enr-2025-0029_ref_018","doi-asserted-by":"crossref","unstructured":"Reiners C, Drozd V, Yamashita S. Hypothyroidism after radiation exposure: brief narrative review. J Neural Transm (Vienna) 127, 1455\u20131466, 2020.","DOI":"10.1007\/s00702-020-02260-5"},{"key":"2026063014591890158_j_enr-2025-0029_ref_019","doi-asserted-by":"crossref","unstructured":"Rodondi N, den Elzen WP, Bauer DC, Cappola AR, Razvi S, Walsh JP, Asvold BO, Iervasi G, Imaizumi M, Collet TH, Bremner A, Maisonneuve P, Sgarbi JA, Khaw KT, Vanderpump MP, Newman AB, Cornuz J, Franklyn JA, Westendorp RG, Vittinghoff E, Gussekloo J; Thyroid Studies Collaboration. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA 304, 1365\u20131374, 2010.","DOI":"10.1001\/jama.2010.1361"},{"key":"2026063014591890158_j_enr-2025-0029_ref_020","doi-asserted-by":"crossref","unstructured":"Rooney MK, Andring LM, Corrigan KL, Bernard V, Williamson TD, Fuller CD, Garden AS, Gunn B, Lee A, Moreno AC, Morrison WH, Phan J, Rosenthal DI, Spiotto M, Frank SJ. Hypothyroidism following radiotherapy for head and neck cancer: a systematic review of the literature and opportunities to improve the therapeutic ratio. Cancers (Basel) 15, 4321, 2023.","DOI":"10.3390\/cancers15174321"},{"key":"2026063014591890158_j_enr-2025-0029_ref_021","doi-asserted-by":"crossref","unstructured":"Skladowski K, Maciejewski B, Golen M, Tarnawski R, Suwinski KSR, Sygula M, Wygoda A. Continuous accelerated 7 days-a week radiotherapy for head-and-neck cancer: long-term results of phase III clinical trial. Int J Radiat Oncol Biol Phys 66, 706\u2013713, 2006.","DOI":"10.1016\/j.ijrobp.2006.05.026"},{"key":"2026063014591890158_j_enr-2025-0029_ref_022","doi-asserted-by":"crossref","unstructured":"Terhaard CH, Kal HB, Hordijk GJ. Why to start the concomitant boost in accelerated radiotherapy for advanced laryngeal cancer in week 3. Int J Radiat Oncol Biol Phys 62, 62\u201369, 2005.","DOI":"10.1016\/j.ijrobp.2004.09.007"},{"key":"2026063014591890158_j_enr-2025-0029_ref_023","doi-asserted-by":"crossref","unstructured":"van Dorp W, van Beek RD, Laven JSE, Pieters R, de Muinck Keizer-Schrama SMPF, van den Heuvel-Eibrink MM. Long-term endocrine side effects of childhood Hodgkin\u2018s lymphoma treatment: a review. Hum Reprod Update 18, 12\u201328, 2012.","DOI":"10.1093\/humupd\/dmr038"},{"key":"2026063014591890158_j_enr-2025-0029_ref_024","doi-asserted-by":"crossref","unstructured":"van Santen HM, van Dijk JE, Rodermond H, Vansenne F, Endert E, de Vijlder JJ, Haveman J, Vulsma T. Endocrine intervention during irradiation does not prevent damage to the thyroid gland. Thyroid 16, 387\u2013395, 2006.","DOI":"10.1089\/thy.2006.16.387"}],"container-title":["Endocrine Regulations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/enr-2025-0029","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T19:47:10Z","timestamp":1782848830000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/enr-2025-0029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,1]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12,12]]},"published-print":{"date-parts":[[2025,1,1]]}},"alternative-id":["10.2478\/enr-2025-0029"],"URL":"https:\/\/doi.org\/10.2478\/enr-2025-0029","relation":{},"ISSN":["1336-0329"],"issn-type":[{"value":"1336-0329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,1]]}}}